Schrödinger, Inc. (SDGR) Q2 2023 Earnings Call Transcript

Schrödinger, Inc. (NASDAQ:SDGR) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ET

Company Participants

Jaren Madden - SVP, IR & Corporate Affairs
Ramy Farid - CEO
Geoff Porges - CFO
Karen Akinsanya - President R&D, Therapeutics

Conference Call Participants

Michael Yee - Jefferies
David Lebowitz - Citigroup
Evan Seigerman - BMO Capital Markets
Vikram Purohit - Morgan Stanley
Matt Hewitt - Craig-Hallum
Gaurav Goparaju - Berenberg Capital Markets
Michael Ryskin - Bank of America
Joseph Catanzaro - Piper Sandler
Chris Shibutani - Goldman Sachs

Operator

Thank you for standing by. Welcome to Schrödinger's Conference Call to review Second Quarter 2023 Financial Results. My name is Chris, and I will be your operator for today's call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. Please be advised that this call is being recorded at the company's request.

Now, I would like to introduce your host for today's conference, Ms. Jaren Madden, Senior Vice President Investor Relations and Corporate Affairs. Please go ahead.

Jaren Madden

Thank you, and good afternoon, everyone. Welcome to today's call during, which we will provide an update on the company and review our second quarter 2023 financial results.

Earlier today, we issued a press release summarizing our financial results and progress across the company, which is available on our website at shordinger.com. Here with me on our call today are Ramy Farid, Chief Executive Officer; Geoff Porges, Chief Financial Officer; and Karen Akinsanya, President of R&D Therapeutics. Following our prepared remarks, we'll open the call for Q&A.

During today's call, management will make statements that are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements related to our outlook for